POZ September 2020
POZ September 2020
In every issue, you’ll find the hottest topics of interest to our readers along with cutting-edge health information.
Also Available On:
Features
Remembering the Passion of Larry Kramer
In this reminiscence about his friend, the founder of POZ shares personal insights on the late author and activist.
What Is Successful Aging With HIV/AIDS?
Researchers study older people living with the virus.
Still Here
Young long-term survivors continue to face challenges.
Editor’s Letter
The Last Song
In remembrance of Larry Kramer, who died in May at age 84, we dedicated our September magazine cover to him.
POZ Q+A
Coping at Home
Longtime HIV advocates share their insights on COVID-19, social justice and living through two pandemics.
POZ Planet
Pages of Larry Kramer
The legendary AIDS activist was also an accomplished author.
New Rules
Supreme Court decisions and a Trump pronouncement on health care affect HIV efforts
Everyday — September 2020
These dates represent milestones in the HIV epidemic.
Fabric of Our Lives
Sewing to remember AIDS losses and to protect against COVID-19
Masked Crusaders
These masks keep HIV messaging in everyone’s face while raising funds for a good cause.
Voices
Positive Again
POZ editor-in-chief Oriol R. Gutierrez Jr. shares his experiences testing antibody positive for COVID-19.
Serving Youth
The nonprofit organization One Heartland shares how COVID-19 threatens the survival of the summer camp it created in response to AIDS.
Spotlight
R.I.P. Larry Kramer
Activists and celebrities remember the longtime HIV advocate on social media.
Basics
Lipodystrophy: Fat Gain and Fat Loss
Abnormal body fat distribution is still a concern for many people living with HIV.
Ask POZ
Ask POZ – September 2020
Ask POZ is an ongoing section on POZ.com dedicated to answering general wellness questions.
Care And Treatment
Long-Acting PrEP Versus Daily Truvada
Cabotegravir injections given every eight weeks as PrEP are even more effective than daily Truvada.
First New KS Treatment in Decades
The immune modulator Pomalyst led to remission in two thirds of people with AIDS-related Kaposi sarcoma.
Fatty Liver and Metabolic Woes
Fatty liver disease is tied to risk of metabolic problems in people with HIV.
The Trouble With a Low Detectable Viral Load
It’s tied to worse health outcomes in people with HIV.
Research Notes
Prevention: PrEP 2-1-1
The 2-1-1 HIV prevention regimen offers an option for those who don’t want to take daily pills.
Treatment: New Type of HIV Med
A mid-stage trial shows islatravir plus Pifeltro shows promise as two-drug HIV regimen.
Cure: Another HIV Cure?
A man with HIV is in long-term viral remission after intensified treatment.
Concerns: ARVs & Inflammation
A recent study links simplified HIV treatment with a greater risk of inflammation.
Heroes
Community Resilience
As president and CEO of AIDS United, Jesse Milan Jr. works tirelessly to end the HIV epidemic in the United States.
Survey
Digital Edition
POZ September 2020
Read the digital edition!
